Testing of susceptibility of Mycobacterium tuberculosis to pyrazinamide: comparison of Bactec method with pyrazinamidase assay
about
Systematic review of mutations in pyrazinamidase associated with pyrazinamide resistance in Mycobacterium tuberculosis clinical isolatespncA mutations as a major mechanism of pyrazinamide resistance in Mycobacterium tuberculosis: spread of a monoresistant strain in Quebec, CanadaCharacterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosisRapid colorimetric testing for pyrazinamide susceptibility of M. tuberculosis by a PCR-based in-vitro synthesized pyrazinamidase methodSurveillance of pyrazinamide susceptibility among multidrug-resistant Mycobacterium tuberculosis isolates from Siriraj Hospital, Thailand.Reduced pyrazinamidase activity and the natural resistance of Mycobacterium kansasii to the antituberculosis drug pyrazinamide.Identification, cloning, and expression of the Escherichia coli pyrazinamidase and nicotinamidase gene, pncA.Comparative evaluation of Löwenstein-Jensen proportion method, BacT/ALERT 3D system, and enzymatic pyrazinamidase assay for pyrazinamide susceptibility testing of Mycobacterium tuberculosisDetection of multidrug resistance in Mycobacterium tuberculosisSequencing of the pncA gene in members of the Mycobacterium tuberculosis complex has important diagnostic applications: Identification of a species-specific pncA mutation in "Mycobacterium canettii" and the reliable and rapid predictor of pyrazinamiRole of metal ions on the activity of Mycobacterium tuberculosis pyrazinamidase.Temperature-mediated heteroduplex analysis for detection of pncA mutations associated with pyrazinamide resistance and differentiation between Mycobacterium tuberculosis and Mycobacterium bovis by denaturing high- performance liquid chromatographyEvaluation of methods for testing the susceptibility of clinical Mycobacterium tuberculosis isolates to pyrazinamide.Molecular identification of streptomycin monoresistant Mycobacterium tuberculosis related to multidrug-resistant W strain.Rapid detection of Mycobacterium tuberculosis and pyrazinamide susceptibility related to pncA mutations in sputum specimens through an integrated gene-to-protein function approachPyrazinamide susceptibility testing in Mycobacterium tuberculosis: a systematic review with meta-analyses.'Z(S)-MDR-TB' versus 'Z(R)-MDR-TB': improving treatment of MDR-TB by identifying pyrazinamide susceptibilityRelationship between pyrazinamide resistance, loss of pyrazinamidase activity, and mutations in the pncA locus in multidrug-resistant clinical isolates of Mycobacterium tuberculosis.Mycobacterium smegmatis has two pyrazinamidase enzymes, PncA and pzaA.Growth inhibition of Mycobacterium tuberculosis by polyoxyethylene stearate present in the BACTEC pyrazinamide susceptibility test.A comprehensive characterization of PncA polymorphisms that confer resistance to pyrazinamide.Prevention of false resistance results obtained in testing the susceptibility of Mycobacterium tuberculosis to pyrazinamide with the Bactec MGIT 960 system using a reduced inoculum.Design, Synthesis and Antitubercular Evaluation of Novel Series of Pyrazinecarboxamide Metal Complexes.
P2860
Q27004697-2E031980-DFC4-43BC-8911-9F24508CA7D0Q28343917-5B9AE3D1-D243-4C77-974F-780ED717A74BQ28379489-396CF845-C423-4CCC-9F71-E0F285C33C68Q28477917-271A6F70-ECC7-4522-889E-C248F2BB9DD5Q33667486-05784A01-4F9B-4BA7-9B2E-BF2F61DD36B2Q33976410-1526B7D9-5EDA-4E49-966F-66E1E025CC47Q35124949-055F32BC-493E-4AD3-A197-BB3F02FABF36Q35690257-21068B44-620D-4A66-80E2-960D914CDAB8Q35690316-C354CF3B-2FA2-42CF-80CA-4D3FA255DC3BQ35690487-22BB6928-DCEA-432A-AD02-B1A7065E1C4DQ36080072-214A76F9-EA34-4A20-AA32-E53E7EC56D3DQ36597670-597C8069-70B9-4F25-8529-DEAF856F6881Q36826734-C76617DF-CB57-458F-BFA2-AD9441A11B5CQ37075105-174E48C8-5D97-4FF3-9008-F260B05CA0DFQ37546819-731D895B-FE42-4ED4-8437-327B2094CB71Q37902409-36F7D0C8-01F2-44CF-878A-C935BB298619Q38514218-5A5B2F30-9335-44B5-8617-45350BF0D474Q39471812-51FF8D77-4125-41B9-B495-4187870F3F1FQ39500129-A700B053-CAC3-4E2B-AA5E-07635983DAF8Q40009718-AE940AC8-9B9A-476C-9220-5913AAE17F6DQ41701192-259B0FB2-C8F1-447B-A20C-0DACC09AEE91Q42127991-314DB040-5CF8-42CA-8AEA-641D9867E2B3Q54969861-AB50217D-AB78-4C00-9AD8-32B294E9FE2F
P2860
Testing of susceptibility of Mycobacterium tuberculosis to pyrazinamide: comparison of Bactec method with pyrazinamidase assay
description
1995 nî lūn-bûn
@nan
1995 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Testing of susceptibility of M ...... thod with pyrazinamidase assay
@ast
Testing of susceptibility of M ...... thod with pyrazinamidase assay
@en
Testing of susceptibility of M ...... thod with pyrazinamidase assay
@nl
type
label
Testing of susceptibility of M ...... thod with pyrazinamidase assay
@ast
Testing of susceptibility of M ...... thod with pyrazinamidase assay
@en
Testing of susceptibility of M ...... thod with pyrazinamidase assay
@nl
prefLabel
Testing of susceptibility of M ...... thod with pyrazinamidase assay
@ast
Testing of susceptibility of M ...... thod with pyrazinamidase assay
@en
Testing of susceptibility of M ...... thod with pyrazinamidase assay
@nl
P2093
P2860
P1476
Testing of susceptibility of M ...... thod with pyrazinamidase assay
@en
P2093
P2860
P304
P407
P577
1995-09-01T00:00:00Z